Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Disodium Gadoxetate
2. Eovist
3. Gadolinium (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanoic Acid Disodium Salt
4. Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid
5. Gadolinium Ethoxybenzyl Dtpa
6. Gadoxetate Disodium
7. Gadoxetic Acid
8. Gadoxetic Acid Disodium
9. Gd-eob-dtpa
1. Eovist
2. Gadoxate
3. Gadoxate Disodium
4. Gadolinium Ethoxybenzyl-dtpa
5. Moli000482
6. Q1928394
7. 2-[[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic Acid;gadolinium(3+)
8. Gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic Acid, Disodium S-[4-(4-ethoxybenzyl)-3,6,9-tris[(carboxy-ko)methyl]-3,6,9-triazaundecandioato)(5-)-k3n3,n6,n9,k2o1,o11]gadolinite(2-)
| Molecular Weight | 684.8 g/mol |
|---|---|
| Molecular Formula | C23H33GdN3O11+3 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 20 |
| Exact Mass | 685.13562 g/mol |
| Monoisotopic Mass | 685.13562 g/mol |
| Topological Polar Surface Area | 205 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 3 |
| Complexity | 739 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Eovist |
| PubMed Health | Gadoxetate (Injection) |
| Drug Classes | Diagnostic Agent |
| Drug Label | EOVIST (gadoxetate disodium) is a paramagnetic contrast agent for MRI. EOVIST is provided as a sterile, clear, colorless to pale yellow aqueous solution for intravenous injection.EOVIST contains the active pharmaceutical ingredient gadoxetate disodiu... |
| Active Ingredient | Gadoxetate disodium |
| Dosage Form | Solution |
| Route | Intravenous |
| Strength | 1.8143gm/10ml (181.43mg/ml); 2.72145gm/15ml (181.43mg/ml) |
| Market Status | Prescription |
| Company | Bayer Hlthcare |
| 2 of 2 | |
|---|---|
| Drug Name | Eovist |
| PubMed Health | Gadoxetate (Injection) |
| Drug Classes | Diagnostic Agent |
| Drug Label | EOVIST (gadoxetate disodium) is a paramagnetic contrast agent for MRI. EOVIST is provided as a sterile, clear, colorless to pale yellow aqueous solution for intravenous injection.EOVIST contains the active pharmaceutical ingredient gadoxetate disodiu... |
| Active Ingredient | Gadoxetate disodium |
| Dosage Form | Solution |
| Route | Intravenous |
| Strength | 1.8143gm/10ml (181.43mg/ml); 2.72145gm/15ml (181.43mg/ml) |
| Market Status | Prescription |
| Company | Bayer Hlthcare |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
15
PharmaCompass offers a list of Gadolinium Ethoxybenzyl Dtpa API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gadolinium Ethoxybenzyl Dtpa manufacturer or Gadolinium Ethoxybenzyl Dtpa supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gadolinium Ethoxybenzyl Dtpa manufacturer or Gadolinium Ethoxybenzyl Dtpa supplier.
PharmaCompass also assists you with knowing the Gadolinium Ethoxybenzyl Dtpa API Price utilized in the formulation of products. Gadolinium Ethoxybenzyl Dtpa API Price is not always fixed or binding as the Gadolinium Ethoxybenzyl Dtpa Price is obtained through a variety of data sources. The Gadolinium Ethoxybenzyl Dtpa Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gd-EOB-DTPA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gd-EOB-DTPA, including repackagers and relabelers. The FDA regulates Gd-EOB-DTPA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gd-EOB-DTPA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gd-EOB-DTPA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gd-EOB-DTPA supplier is an individual or a company that provides Gd-EOB-DTPA active pharmaceutical ingredient (API) or Gd-EOB-DTPA finished formulations upon request. The Gd-EOB-DTPA suppliers may include Gd-EOB-DTPA API manufacturers, exporters, distributors and traders.
click here to find a list of Gd-EOB-DTPA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gd-EOB-DTPA DMF (Drug Master File) is a document detailing the whole manufacturing process of Gd-EOB-DTPA active pharmaceutical ingredient (API) in detail. Different forms of Gd-EOB-DTPA DMFs exist exist since differing nations have different regulations, such as Gd-EOB-DTPA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Gd-EOB-DTPA DMF submitted to regulatory agencies in the US is known as a USDMF. Gd-EOB-DTPA USDMF includes data on Gd-EOB-DTPA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gd-EOB-DTPA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Gd-EOB-DTPA suppliers with USDMF on PharmaCompass.
A Gd-EOB-DTPA written confirmation (Gd-EOB-DTPA WC) is an official document issued by a regulatory agency to a Gd-EOB-DTPA manufacturer, verifying that the manufacturing facility of a Gd-EOB-DTPA active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Gd-EOB-DTPA APIs or Gd-EOB-DTPA finished pharmaceutical products to another nation, regulatory agencies frequently require a Gd-EOB-DTPA WC (written confirmation) as part of the regulatory process.
click here to find a list of Gd-EOB-DTPA suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gd-EOB-DTPA as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Gd-EOB-DTPA API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Gd-EOB-DTPA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Gd-EOB-DTPA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gd-EOB-DTPA NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Gd-EOB-DTPA suppliers with NDC on PharmaCompass.
Gd-EOB-DTPA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gd-EOB-DTPA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gd-EOB-DTPA GMP manufacturer or Gd-EOB-DTPA GMP API supplier for your needs.
A Gd-EOB-DTPA CoA (Certificate of Analysis) is a formal document that attests to Gd-EOB-DTPA's compliance with Gd-EOB-DTPA specifications and serves as a tool for batch-level quality control.
Gd-EOB-DTPA CoA mostly includes findings from lab analyses of a specific batch. For each Gd-EOB-DTPA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gd-EOB-DTPA may be tested according to a variety of international standards, such as European Pharmacopoeia (Gd-EOB-DTPA EP), Gd-EOB-DTPA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gd-EOB-DTPA USP).